Acute pancreatitis: The pathophysiological role of cytokines and integrins. New trend for treatment?

Digestive Surgery

Volumn 16, Issue 5, 1999, Pages 347-362

  Osman, Maher O ^a,b   Jensen, Steen L ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b NONE   (Egypt)

Author keywords

Acute pancreatitis; Anticytokine treatment; Integrins; Interleukins

Indexed keywords

CELL ADHESION MOLECULE; CYTOKINE; FUSIDATE SODIUM; IMMUNOMODULATING AGENT; INTEGRIN; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MONOCLONAL ANTIBODY; RECOMBINANT INTERLEUKIN 10; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PANCREATITIS; HUMAN; IMMUNOASSAY; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE; LUNG INJURY; MORTALITY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROGNOSIS; REVIEW;

ACUTE DISEASE; ANIMALS; CYTOKINES; HUMANS; INTEGRINS; PANCREATITIS;

EID: 0032711727     PISSN: 02534886     EISSN: None     Source Type: Journal    
DOI: 10.1159/000018746     Document Type: Review

References (164)

1. Moynihan B: Acute pancreatitis. Ann Surg 1925;81:132-142.
2. Steinberg W, Tenner S: Acute pancreatitis. N Engl J Med 1994;330:1198-1210.
3. Marshall JB: Acute pancreatitis: A review with an emphasis on new development. Arch Intern Med 1993;153:1185-1198.
4. De Beaux AC, Palmer KR, Carter DC: Factors influencing morbidity and mortality in acute pancreatitis: An analysis of 279 cases. Gut 1995;37:121-126.
5. Jacobs ML, Daggett WM, Civetta JM, Vasu MA, Lawson DW, Warshaw AL, Nardi GL, Bartlett MK: Acute pancreatitis: Analysis of factors influencing survival. Ann Surg 1977; 185:43-51.
6. Stanten R, Frey CF: Comprehensive management of acute necrotizing pancreatitis and pancreatic abscess. Arch Surg 1990;125:1269-1274.
7. White TT, Heimback DM: Sequestrectomy and hyperalimentation in the treatment of hemorrhagic pancreatitis. Am J Surg 1976;132: 270-275.
8. Renner IG, Savage WT, Pantoja JL, Renner VJ: Death due to acute pancreatitis. A retrospective analysis of 405 autopsy cases. Dig Dis Sci 1985;30:1005-1018.
9. Glasbrenner B, Adler G: Pathophysiology of acute pancreatitis. Hepatogastroenterology 1993;40:517-521.
10. Steinberg WM, Schlesselman SE: Treatment of acute pancreatitis. Comparison of animal and human studies. Gastroenterology 1987;93: 1420-1427.
11. Lerch MM, Adler G: Experimental animal models of acute pancreatitis. Int J Pancreatol 1994;15:159-170.
12. Lerch MM, Adler G: Experimental pancreatitis. Curr Opin Gastroenterol 1993;9:752-759.
13. Banerjec AK, Galloway SW, Kingsnorth AN: Experimental models of acute pancreatitis. Br J Surg 1994;81:1096-1103.
14. Rattner DW: Experimental models of acute pancreatitis and their relevance to human disease. Scand J Gastroenterol 1996;31(suppl 219):6-9.
15. Lankisch PG, Ihse I: Bile-induced acute experimental pancreatitis. Scand J Gastroenterol 1987;22:257-260.
16. Senninger N: Bile-induced pancreatitis. Eur Surg Res 1002;24(suppl 1):68-73.
17. Bilchik AJ, Leach SD, Zucker KA, Modlin IM: Experimental models of acute pancreatitis. J Surg Res 1990;48:639-647.
18. Lowry SF: Cytokine meditors of immunity and inflammation. Arch Surg 1993;128:1235-1241.
19. Balkwill FR, Burke F: The cytokine network. Immunol Today 1989;10:299-303.
20. Roitt I: The production of effectors; in Roitt I (ed): Essential Immunology. Oxford, Blackwell Scientific, 1994, pp 173-192.
21. Ko Y-C, Mukaida N, Panyutich A, Voitenok NN, Matsushima K, Kawai T, Kashara T: A sensitive enzyme-linked immunosorbent assay for human interleukin-8. J Immunol Methods 1992;149:227-235.
22. Gearing AJH, Cartwright JE, Wadhwa M: Biological and immunological assays for cytokines; in Thomson A (ed): The Cytokine Handbook. San Diego, Academic Press, 1991, pp 339-355.
23. Tonnesen E, Christensen VB, Toft P: The role of cytokines in cardiac surgery. Int J Cardiol 1996;53(suppl):1-10.
24. McKay CJ, Gallagher G, Brooks B, Imrie CW, Baxter JN: Increased monocyte cytokine production in association with systemic complications in acute pancreatitis. Br J Surg 1996;83: 919-923.
25. Gesser B, Deleuran B, Lund M, Vestergaard C, Lohse N, Deleuran M, Jensen SL, Pedersen SS, Thestrup-Pedersen K, Larsen CG: Interlcukin-8 induces its own production in CD4+ lymphocytes: A process regulated by interlcukin-10. Biochem Biophys Res Commun 1995;210: 666-669.
26. Nagai H, Henrich H, Wunsch PH, Fischbach W, Mossner J: Role of pancreatic enzymes and their substrates in autodigestion of the pancreas. In vitro studies with isolated rat pancreatic acini. Gastroenterology 1989;96:838-847.
27. Ohlsson K: Role of protcases in acute pancreatitis: in Aasen AO, Risberg B (cds): Surgical Pathophysiology. Chur, Harwood Academic 1990, pp 423-433.
28. Rinderknecht H: Activation of pancreatic zymogens. Normal activation, premature intrapancrcatic activation, protective mechanisms against inappropriate activation. Dig Dis Sci 1986;31:314-321.
29. Rinderknecht H: Fatal pancreatitis, a consequences of excessive leukocyte stimulation? Int J Pancreatol 1988;3:105-112.
30. Weiss SJ: Tissue destruction by neutrophils. N Engl J Med 1989;320:365-376.
31. Dominguez-Munoz JE, Carballo F, Garcia MJ, de Diego JM, Rabago L, Simon MA, de la Morena J: Clinical usefulness of polymorphonuclear elastase in predicting the severity of acute pancreatitis: Results of a multicentre study. Br J Surg 1991;78:1230-1234.
32. Gross V, Scholmerich J, Leser H-G, Salm R, Lausen M, Ruckauer K, Schoffel U, Lay L, Heinisch A, Farthmann EH, Gerok W: Granulocyte elastase in assessment of severity of acute pancreatitis: Comparison with acute-phase proteins C-reactivc protein, α1-antitrypsin and protease inhibitor α2-macroglobulin. Dig Dis Sci 1990;35:97-105.
33. Uhl W, Buchler M, Malfertheiner P, Martini M, Beger HG: PMN-elastase in comparison with CRP, antiprotcases, and LDH as indicators of necrosis in human acute pancreatitis. Pancreas 1991;6:253-259.
34. Scholmerich J, Sehumichen C, Lauwen M, Gross V, Leser H.-G., Lay L, Farthmann EH, Gerok V: Scintigraphic assessment of leukocyte infiltration in acute pancreatitis using technetium-99m-hexamethyl propylene amine oxinc as leukocyte label. Dig Dis Sci 1991;36:65-70.
35. Barie PS, Tahamont MV, Malik AB: Prevention of increased pulmonary vascular permeability after pancreatitis by granulocytc depletion in sheep. Am Rev Respir Dis 1982;126: 904-908.
36. Rutledge PL, Saluza AK, Powers RE, Steer ML: Role of oxygen-derived free radicals in diet-induced hemorrhagic pancreatitis in mice. Gastroenterology 1987;93:41-47.
37. Braganza JM, Holmes AM, Morton AR, Stalley L, Ku R, Kishen R: Acetylcysteine to treat complications of pancreatitis. Lancet 1986;i: 914-915.
38. Inouc S, Nakao A, Kishimoto W, Murakami H, Itoh K, Harada A, Nonami T, Takagi H: Anti-neutrophil antibody attenuates the severity of acute lung injury in rats with experimental acute pancreatitis. Arch Surg 1995;130:93-98.
39. Han S-L, Abe Y, Miyauchi K, Watanabe Y, Sato N, Kimura S: Therapeutic efficacy of an anti-neutrophil monoclonal antibody, Urge-8, against acute necrotizing pancreatitis in rats. Surgery 1996;119:585-591.
40. Gross V, Leser H-G, Heinisch A, Scholmerich J: Inflammatory mediators and cytokines: New aspects of the pathophysiology and assessment of severity of acute pancreatitis? Hepatogastroenterology 1993;40:522-530.
41. Kusske AM, Rongione AJ, Reber HA: Cytokines and acute pancreatitis (editorial). Gastroenterology 1996;110:639-642.
42. Molloy RG, Mannick JA, Rodrick ML: Cytokines, sepsis and immunomodulation. Br J Surg 1993;80:289-297.
43. Welbourn CRB, Young Y: Endotoxin, septic shock and acute lung injury: Neutrophils, macrophages and inflammatory mediators. Br J Surg 1992;79:998-1003.
44. Darville T, Giroir B, Jacobs R: The systemic inflammatory response syndrome (SIRS): Immunology and potential immunotherapy. Infection 1993;21:279-290.
45. Sameshima H, Ikei S, Mori K, Yamaguchi Y, Egami H, Misumi M, Moriyasu M, Ogawa M: The role of tumor necrosis factor-α in the aggravation of caerulein-induced pancreatitis in rats. Int J Pancreatol 1993;14:107-115.
46. Okusawa S, Geltand JA, Ikejima T, Connolly RJ, Dinarello CA: Interleukin-1 induces a shock-like state in rabbits: Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. J Clin Invest 1988;81:1162-1172.
47. Tracey KJ, Beutler B, Lowry SF, Merryweather J, Wolpe S, Milsark IW, Hanri RJ, Fahey TJ III, Zentella A, Albert JD, Shires GT, Cerami A: Shock and tissue injury induced by recombinant human cachectin. Science 1986;234:470-474.
48. Scholmerich J: Interleukins in acute pancreatitis. Scand J Gastroenterol 1996;31(suppl 219): 37-42.
49. McKay C, Imrie CW, Baxter JN: Mononuclear phagocyte activation and acute pancreatitis. Scand J Gastroenterol 1996;31(suppl 219):32-36.
50. Spinas GA, Blocsch D, Keller U, Zimmerli W, Cammisuli S: Pretreatment with ibuprofen augments circulating tumor necrosis factor, interleukin-6 and elastase during acute endotoxacmia. J Infect Dis 1991;163:89-95.
51. Martich GD, Danner RL, Ceska M, Suffredini AF: Detection of interleukin-8 and tumor necrosis factor in normal human after intravenous endotoxin: The effects of anti-inflammatory agents. J Exp Med 1991;173:1021-1024.
52. Beutler B, Cerami A: Cachectin: More than a tumor necrosis factor. N Engl J Med 1987;316: 379-385.
53. Manogue KR, van Deventer SJH, Cerami A: Tumor necrosis factor alpha or cachectin; in Thomson A (ed): The Cytokine Handbook. San Diego, Academic Press, 1991, pp 241-255.
54. Laster SM, Wood JG, Gooding LR: Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis. J Immunol 1988; 141:2629-2634.
55. Gamble R, Harlan JM, Klebanoff SJ, Vadas MA: Stimulation of the adherence of neutrophils to umbilical vein endothelium by recombinant tumor necrosis factor. Proc Natl Acad Sci USA 1985;82:8667-8671.
56. Yutaka A, Sekiya S, Yamasita T, Sendo F: Vascular hyperpermeability induced by tumor necrosis factor and its agumentation by IL-1 and IFN-γ is inhibited by selective depletion of neutrophils with a monoclonal antibody. J Immunol 1990;145:2902-2907.
57. Tsujimoto M, Yokota S, Vilcek J, Wiessman G: Tumor necrosis factor provokes Superoxide generation from neutrophils. Biochem Biophys Res Commun 1986;137:1094-1099.
58. Formela LJ, Galloway SW, Kingsnorth AN: Inflammatory mediators in acute pancreatitis. Br J Surg 1995;82:6-13.
59. Norman J, Franz M, Riker A, Fabri PJ, Gower WR: Rapid elevation of systemic cytokines during acute pancreatitis and their origination within the pancreas. Surg Forum 1994;45:148-150.
60. Grewal HP, Kotb M, Mohey el Din AB, Ohman M, Salem A, Gaber L, Gaber AO: Induction of tumor necrosis factor in severe acute pancreatitis and its subsequent reduction after hepatic passage. Surgery 1994;115:213-221.
61. Hughes CB, Gaber LW, Kotb M, Mohey el Din AB, Pabst M, Gaber AO: Induction of acute pancreatitis in germ-free rats: Evidence of a primary role for tumor necrosis factor-alpha. Surgery 1995;117:201-205.
62. Dolan S, Campbell G, McCluggage G, Halliday MI, Rowlands BJ: Biphasic tumor necrosis (TNF) release in experimental acute pancreatitis (abstract). Gut 1994;35:575.
63. Osman MO, Lausten SB, Jacobsen NO, Kristensen JU, Deleuran B, Larsen CG, Jensen SL: Graded experimental acute pancreatitis: Monitoring of a renewed rabbit model focusing on the production of interleukin-8 (IL-8) and CD1 1b/CD18. Eur J Gastroenterol Hepatol, in press.
64. De Beaux AC, Goldie AS, Ross JA, Carter DC, Fearon KCH: Serum concentrations of inflammatory mediators related to organ failure in patients with acute pancreatitis. Br J Surg 1996;83:349-353.
65. Exlcy AR, Leese T, Holliday MP, Swann RA, Cohen J: Endotoxaemia and serum tumor necrosis factor as prognostic markers in severe acute pancreatitis. Gut 1992;33:1126-1128.
66. Banks RE, Evans SW, Alexander D, McMahon MJ, Whicher JT: Is fatal pancreatitis a consequence of excessive leukocyte stimulation? The role of tumor necrosis factor α. Cytokinc 1991; 3:12-16.
67. Hughes CB, Henry J, Kotb M, Lobaschevsky A, Sabek O, Gaber AO: Up-regulation of TNF-α mRNA in the rat spleen following induction of acute pancreatitis. J Surg Res 1995;59:687-693.
68. Norman JG, Fink GW, Franz MG: Acute pancreatitis induces intrapancreatic tumor necrosis factor gene expression. Arch Surg 1995;130: 966-970.
69. Formela LJ, McLaughlin PJ, Flanagan BF, Southern SN, Giles TE, McDicken IF, Kingsnorth AN: Demonstration of tumor necrosis factor in pancreatic acinar cells by in situ hybridization in a model of acute pancreatitis (abstract). Gut 1994;35:575.
70. Dinarello CA, Wolff SM: The role of interleukin-1 in disease. N Engl J Med 1993;328:106-113.
71. Calandra T, Baumgartner JD, Grau GE, Wu M-M, Lambert P-H, Schellekens J, Verhoef J, Glauser MP, The Swiss-Dutch J5 Immunoglobulin Study Group: Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-alpha and interferon-gamma in the serum of patients with septic shock. J Infect Dis 1990;161:982-987.
72. Grzelak I, Olszewski WL, Rowinski W: Blood mononuclear cell production of IL-1 and IL-2 following moderate surgical trauma. Eur Surg Res 1989;21:114-122.
73. Norman J, Fink G, Carter G, Rosemurgy A, Franz M: Multiple organ cytokine gene expression induced by acute pancreatitis (abstract). Gastroenterology 1995;108:1236.
74. Norman JG, Franz MG, Fink GS, Messina J, Fabri PJ, Gower WR, Carey LC: Decreased mortality of severe acute pancreatitis after proximal cytokine blockade. Ann Surg 1995; 221:625-634.
75. Norman JG, Fink G, Franz M, Guffey J, Carter G, Davison B, Sexton C, Glaccum M: Active interleukin-1 receptor required for maximal progression of acute pancreatitis. Ann Surg 1996;223:163-169.
76. Fink GW, Norman JG: Intrapancreatic interleukin-1β gene expression by specific leukocyte populations during acute pancreatitis. J Surg Res 1996;63:369-373.
77. Norman JG, Fink GW, Sexton C, Carter G: Transgenic animals demonstrate a role for the IL-1 receptor in regulating IL-1β gene expression at steady-state and during systemic stress induced by acute pancreatitis. J Surg Res 1996; 63:231-236.
78. Pianko S, Bellomo R, Tipping P, Farragher I, Korman MG: Elevated serum IL-8 and TNF arc associated with acute pancreatitis (abstract). Gastroenterology 1993;104:328.
79. Biffl WL, Moore EE, Moore FA, Peterson VM: Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation. Ann Surg 1996;224:647-664.
80. Helfgott DC, Tatter SB, Santhanam U, Clarick RH, Bhardwaj N, May LT, Sehgal PB: Multiple forms of IFN-β2/IL-6 in serum and body fluids during acute bacterial infection. J Immunol 1989;142:948-953.
81. Viedma JA, Perez-Mateo M, Dominguez JE, Carballo F: Role of interleukin-6 in acute pancreatitis; Comparison with C-reactive protein and phospholipase A. Gut 1992;33:1264-1267.
82. Heath DI, Cruickshank A, Gudgeon M, Jehanli A, Shenkin A, Imrie CW: Role of interleukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis. Gut 1993;34: 41-45.
83. Leser H-G, Gross V, Seheibenbogen C, Heinisch A, Salm R, Lausen M, Ruckauer K, Andreesen R, Farthmann EH, Scholmerich J: Elevation of serum interleukin-6 concentration precedes acute-phase response and reflects severity in acute pancreatitis. Gastroenterology 1991;101:782-785.
84. Curley PJ, McMahon MJ, Lancaster F, Banks RE, Barclay GR, Shefta J, Boylston AW, Whicher JT: Reduction in circulating levels of CD4-positive lymphocytes in acute pancreatitis; relationship to endotoxin, interleukin-6 and disease severity. Br J Surg 1993;80:1312-1315.
85. Vogt W, Messmann H, Heinisch A, Linseis A, Holstege A, Scholmerich J, Leser H-G: Does ERP induce an acute phase response? Serum concentrations of enzymes, leukocytes, IL-6 and CRP after ERP (abstract). Int J Pancreatol 1994;16:323.
86. Tran DD: Interleukin-6 in the early assessment of acute pancreatitis (Letter). Gut 1993;34: 1467.
87. Baggiolini M, Walz A, Kunkel SL: Neutrophilactivating peptide-1/interleukin-8, a novel cytokine that activates neutrophils. J Clin Invest 1989;84:1045-1049.
88. Larsen CG, Anderson AO, Appella E, Oppenheim JJ, Matsushima K: The neutrophil-activating protein (NAP-1) is also chemotactic for T-lymphocytes. Science 1989;243:1464-1466.
89. Thelen M, Peveri P, Kernen P, von Tscharner V, Walz A, Baggiolini M: Mechanism of neutrophil activation by NAF, a novel monocyte-derived peptide agonist. FASEB J 1988;2: 2702-2706.
90. Willems J, Joniau M, Cinque S, Van Damme J: Human granulocyte chemotactic peptide (IL-8) as a specific neutrophil degranulator: Comparison with other monokines. Immunology 1989; 67:540-542.
91. Smart SJ, Casale TB: TNF-α-induced transendothelial neutrophil migration is IL-8 dependent. Am J Physiol 1994;266:L238-L245.
92. Deaubien BC, Collins PD, Jose PJ, Totty NF, Hasuan J, Waterfield MD, Williams TJ: A novel neutrophil chemoattraetant generated during inflammatory reaction in the rabbit peritoneal cavity in vivo. Purification, partial amino acid sequence and structural relationship to interleukin-8. Bioehem J 1990;271:797-801.
93. Kunkel SL, Standiford T, Kasahara K, Stricter RM: Interleukin-8 (IL-8): The major neutrophil chemotactic factor in the lung. Exp Lung Res 1991;17:17-23.
94. Metinko AP, Kunkel SL, Standiford TJ, Stricter RM: Anoxia-hyperoxia: A model of ischaemia reperfusion for interleukin-8 expression by monocytes (abstract). Am Rev Respir Dis 1991;143:232.
95. Donnelly SC, Strieter RM, Kunkel SL, Walz A, Robertson CR, Carter DC, Grant IS, Pollok AJ, Haslett C: Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient group. Lancet 1993;341:643-647.
96. Miller EJ, Cohen AB, Nagao S, Griffith D, Maunder RJ, Martin TR, Weiner-Kronish JP, Sticherling M, Christophers E, Matthay MA: Elevated levels of NAP-1/Interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. Am Rev Respir Dis 1992;146:427-432.
97. Harada A, Sekido N, Kuno K, Akiyama M, Kashara T, Nakanishi L, Mukaida N, Matsushima K: Expression of recombinant rabbit IL-8 in Eschericia coli and establishment of the essential involvement of IL-8 in recruiting neutrophils into lipopolysaccharide-induced inflammatory site of rabbit skin. Int Immunol 1993;5:681-690.
98. Gross V, Andreesen R, Leser H-G, Ceska M, Liehl E, Lausen M, Farthmann EH, Scholmerich J: Interleukin-8 and neutrophil activation in acute pancreatitis. Eur J Clin Invest 1992; 22:200-203.
99. Schulz HU, Schmidt D, Kunz D, Meyer F, Lippert H: Altered immune function in acute pancreatitis. Pathogenetic role and prognostic indicator? (abstract). Digestion 1993;54:307-308.
100. Ventrucci M, Gronchetti P, Baraldini M, Boni P, Garulli L, Liguori L: Behavior of serum interleukin-8 during the course of acute pancreatitis. Comparison with serum interleukin-6 and C-reactive protein (abstract). Digestion 1993;54:314.
101. Kingsnorth AN, Galloway SW, Formela LJ: Randomized, double-blind phase II trial of Lexipafant, a platelet-activating factor antagonist, in human acute pancreatitis. Br J Surg 1995;82:1414-1420.
102. Abe Re, Shimosegawa T, Kimura K, Abe T, Kashimura J, Koizumi M, Toyota T: The role of endogenous glucocorticoids in rat experimental models of acute pancreatitis. Gastroenterology 1995;109:933-943.
103. Moore KW, O'Garra A, deWaal Malefyt R, Vieira P, Mosmann TR: Interleukin-10. Annu Rev Immunol 1993;11:165-190.
104. Mosmann TR: Interleukin-10: in Thomsan A (ed): The Cytokine Handbook. San Diego, Academic Press, 1994, pp 223-237.
105. Banchereau J: Interleukin-4; in Thomsan A (cd): The Cytokine Handbook. San Diego, Academic Press, 1991, pp 119-148.
106. Osborn L: Leukocyte adhesion to endothelium in inflammation. Cell 1990;62:3-6.
107. Springer TA: Adhesion receptors of the immune system. Nature 1990;346:425-434.
108. Peri G, Chiaffarino F, Bernascooni S, Padura IM, Mantovani A: Cytotoxicity of activated monocytes on endothelial cells. J Immunol 1990;144:1444-1448.
109. Tamatani T, Kotani M, Miyasaka M: Characterization of the rat leukocyte integrin: CD11/ CD 18 by the use of monoclonal antibodies. Eur J Immunol 1991;21:627-633.
110. Lee J, Vilcek J: Tumor necrosis factor and interleukin-1: Cytokines with multiple overlapping biological activities. Lab Invest 1987; 56:234-248.
111. Detmers PA, Lo SK, Olsen Egbert E, Walz A, Baggiolini M, Cohn ZA: Neutrophil-activating protein-1/interleukin-8 stimulates the binding activity of the leukocyte adhesion receptor CD11b/CD18 on human neutrophils: J Exp Med 1990;171:1155-1162.
112. Newman W, Beal LD, Carson CW, Hunder GG, Graben N, Randhawa ZI, Gopal TV, Wiener-Kronish J, Matthay MA: Soluble E-selectin is found in supernatants of activated endothelial cells and is elevated in the serum of patients with septic shock. J Immunol 1993;150:644-654.
113. Formela LJ, Galloway SW, Kingsnorth AN: E-selectin in acute pancreatitis (abstract). Gut 1994;35:574.
114. Wassef W, Boyd J, Foxx-Omstein A, Sessler C, Fowler B, Zfass AM, Everette S: The role of ICAM-1 in predecting the severity of acute pancreatitis (abstract). Gastroenterology 1995;108:818.
115. Snyder F: Platelet-activating factor and related acetylated lipids are potent biologically active cellular mediators. Am J Physiol 1992; 259:C696-C708.
116. Rosam AC, Wallace JL, Whittle BJR: Potent ulcerogenic actions of platelet-activating factor on the stomach. Nature 1986;319:54-56.
117. Anderson BO, Bensard DB, Harken AH: The role of platelet-activating factor and its antagonists in shock, sepsis, and multiple organ failure. Surg Gynccol Obstet 1991;172:415-424.
118. Milhoan KA, Lane TA, Bloor CM: Hypoxia induces endothelial cells to increase their adherence for neutrophils: Role of PAF. Am J Physiol 1992;263:H956-H962.
119. Zhou W, Levine BA, Olson MS: Platelet-activating factor: A mediator of pancreatic inflammation during caerulein hyperstimulation. Am J Pathol 1993;142:1504-1512.
120. Sandoval D, Gukovskaya A, Reavey P, Gukovsky S, Sisk A, Braquet P, Pandol SJ, Poucell-Hatton S: The role of neutrophils and platelet-activating factor in mediating experimental pancreatitis. Gastroenterology 1996; 111:1081-1091.
121. Juworek J, Konturck SJ: Effects of prostaglandins (PG) of E, F, and I series leukotrienes (I.T) and platelet-activating factor (PAF) on amylase release from isolated pancreatic acini (abstract). Digestion 1992;52:92.
122. Emanuelli G, Montrucchio G, Gaia E, Dughera L, Corvrtti G, Gubetta L: Experimental acute pancreatitis induced by platelet-activating factor in rabbits. Am J Pathol 1989;314: 315-326.
123. Kald B, Kald A, Ihse I, Tagesson C: Release of platelet-activating factor in acute experimental pancreatitis. Pancreas 1993;8:440-442.
124. Dabrowski A, Gabryclewicz A, Chyczewski L: The effect of platelet activating factor antagonist (BN52021) on cerulein-induced acute pancreatitis with reference to oxygen radicals. Int J Pancreatol 1991;8:1-11.
125. Formela LJ, Wood LM, Whittaker M, Kingsnorth AN: Amelioration of experimental acute pancreatitis with a platelet-activating factor antagonist. Br J Surg 1994;81:1783-1785.
126. Dinarello CA, Gelfand JA, Wolff SM: Anticytokine strategies in the treatment of the systemic inflammatory response syndrome. JAMA 1993;269:1829-1835.
127. Grewal HP, Mohey el-Din AB, Gaber L, Kotb M, Gaber AO: Amelioration of the physiologic and biochemical changes of acute pancreatitis using an anti-TNF-α polyclonal antibody. Am J Surg 1994;167:214-219.
128. Hughes CB, Gaber LW, Mohey el-Din AB, Grewal HP, Kotb M, Mann L, Gaber AO: Inhibition of TNF-α improves survival in an experimental model of acute pancreatitis. Am Surg 1996;62:8-13.
129. Norman JG, Fink GW, Messina J, Carter G, Franz MG: Timing of tumor necrosis factor antagonism is critical in determining outcome in murinc lethal acute pancreatitis. Surgery 1996;120:515-521.
130. Guice KS, Oldham KT, Remick DG, Kunkel SL, Ward PA: Anti-tumor necrosis factor antibody augments edema formation in caerulein-induced acute pancreatitis. J Surg Res 1991;51:495-499.
131. Norman J, Franz M, Messina J, Riker A, Fabri PJ, Rosemurgy AS, Gower WR: Interleukin-1 receptor antagonist decreases severity of experimental acute pancreatitis. Surgery 1995;117:648-655.
132. Tanaka N, Murata A, Uda K, Toda H, Kato T. Hayashida H, Matsuura N, Mori T: Interleukin-1 receptor antagonist modifies the changes in vital organs induced by acute necrotizing pancreatitis in a rat experimental model. Crit Care Med 1995;23:901-908.
133. Osman MO, Kristensen JU, Jacobsen NO, Lausten SB, Deleuran B, Deleuran M, Gesser B, Matsushima K, Larsen CG, Jensen SL: A monoclonal anti-IL-8 antibody (WS-4) inhibits cytokine response and acute lung injury in experimental severe acute necrotizing pancreatitis in rabbits. Gut 1988, in press.
134. Eichacker PQ, Farese A, Hoffman WD, Banks SM, Mouginis T, Richmond S, Kuo GC, Macvittie TJ, Natauson C: Leukocyte CD11b/CD18 antigen-directed monoclonal antibody improves early survival and decrease hypoxaemia in dogs challenged with tumor necrosis factor. Am Rev Respir Dis 1992;145:1023-1029.
135. Inoue S, Nakao A, Kishimoto W, Murakami H, Harada A, Nonami T, Takagi H: LFA-1 (CD11a/CD18) and ICAM-1 (CD54) antibodies attenuate superoxide anion release from polymorphonuclear leukocytes in rats with experimental acute pancreatitis. Pancreas 1996;12:183-188.
136. Gesser B, Lund M, Lohse N, Vestergaard C, Matsushima K, Sindet-Pedersen S, Jensen SL, Thestrup-Pedersen K, Larsen CG: IL-8 induces T cell chemotaxis, suppresses IL-4, and up-regulates IL-8 production by CD4+ T cells. J Leukocyte Biol 1996;59:407-411.
137. Florentine DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A: IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991;147:3815-3822.
138. Bean AGD, Freiberg RA, Andrade S, Menon S, Zlotnik A: Interleukin 10 protects mice against staphylococcal enterotoxin B-induced lethal shock. Infect Immun 1993;61:4937-4939.
139. Howard M, Muchamuel T, Andrade S, Menon S: Interleukin 10 protects mice from lethal endotoxaemia. J Exp Med 1993;177: 1205-1208.
140. Gerard C, Bruyns C, Marchant A, Abramowicz D, Vandenabeele P, Delvaux A, Fiers W, Goldman M, Velu T: Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimenal endotoxaemia. J Exp Med 1993;177:547-550.
141. Van Lacthem J-L, Marchant A, Delvaux A, Goldman M, Robberecht P, Velu T, Deviere J: Interleukin 10 prevents necrosis in murine experimental acute pancreatitis. Gastroenterology 1995;108:1917-1922.
142. Kusske AM, Rongione AJ, Ashley SW, McFadden DW, Reber HA: Interleukin-10 prevents death in lethal necrotizing pancreatitis in mice. Surgery 1996;120:284-289.
143. Rongione AJ, Kusske AM, Kwan KY, Ashley SW, Reber HA, McFadden DW: Interleukin 10 reduces the severity of acute pancreatitis in rats. Gastroenterology 1997;112:960-967.
144. Gesser B, Leffers H, Jinquan T, Vestergaard C, Kirstein N, Sindet-Pedersen S, Jensen SL, Thestrup-Pedersen K, Larsen CG: Identification of a functional domain on human IL-10. Proc Nat Acad Sci 1997;94:14620-14625.
145. Osman MO, Jacobsen NO, Kristensen JU, Deleuran B, Deleuran M, Gesser B, Larsen CG, Jensen SL: IT 9302, a synthetic IL-10 agonist diminishes acute lung injury in rabbits with acute necrotizing pancreatitis. Surgery 1998, in press.
146. Wood JJ, Rodrick ML, O'Mahony JB, Palder SB, Saporoschetz I, D'Eon P, Mannick JA: Inadequate interleukin-2 production: A fundamental deficiency in patients with major burns. Ann Surg 1984;200:311-319.
147. Moss NM, Gough DB, Jordan AL, Grbic JT, Rodrick ML, Mannick JA: Temporal correlation of impaired immune response after thermal injury with susceptibility to infection in a murine model. Surgery 1988;104:882-887.
148. Curley P, Nestor M, Collins K, Saporoschetz I, Mendez M, Mannick JA, Rodrick ML: Decreased interleukin-2 production in murine acute pancreatitis: Potential for immunomodulation. Gastroenterology 1996;110:583-588.
149. Pezzilli R, Billi P, Gullo L, Beltrandi E, Maldini M, Mancini R, Incorvaia L, Miglioli M: Behavior of serum soluble interleukin-2 receptor, soluble CD8 and soluble CD4 in the early phases of acute pancreatitis. Digestion 1994;55:268-273.
150. Widdison AL, Karanjia ND, Alveraz C, Reber HA: Influence of Levamisole on pancreatic infection in acute pancreatitis. Am J Surg 1992;163:100-104.
151. Browder IW, Sherwood E, Williams D, Jones E, McNamee R, Diluzio N: Protective effect of Glucan-enhanced macrophage function in experimental pancreatitis. Am J Surg 1987; 153:25-33.
152. Munck A, Guyre PM, Holbrook NJ: Physiological functions of glueocorticoids in stress and their relation to pharmacological actions. Endocr Rev 1984;5:25-44.
153. Zanker B, Walz A, Wieder KJ, Strom TB: Evidence that glueocorticoids block expression of the human interleukin-6 gene by accessory cells. Transplantation 1990;49:183-185.
154. Beutler B, Krochin N, Milsark IW, Luedke C, Cerami A: Control of cachectin (tumor necrosis factor) synthesis: Mechanisms of endotoxin resistance. Science 1986;232:977-980.
155. Cech AC, Shou J, Gallagher H, Daly JM: Glucocorticoid receptor blockade reverses post-injury macrophage suppression. Arch Surg 1994;129:1227-1232.
156. Monto GL, Guillan RA, Lee SH, Watanabe I: Assessment of corticosteroid treatment of ethionine pancreatitis in the rabbit. Am J Gastroenterol 1983;78:63-67.
157. de Dios I, San Roman JI, Manso M, Calvo JJ, Lopez MA: Glucocorticoids effects on exocrine pancreatic in caerulein-induced acute pancreatitis in the rat. Arch Int Physiol Biochim 1990;98:361-370.
158. Osman MO, Jacobsen NO, Kristensen JU, Larsen CG, Jensen SL: Beneficial effects of hydrocortisone in a model of experimental acute pancreatitis. Eur J Surg, in press.
159. Bendtzen K, Diamant M, Horn T, Pedersen C, Buschard K: Effect of fusidic acid on interleukin-1 (IL-1) and IL-6-induced pancreatic β-cell functions in rats. J Endocrinol 1992; 132:345-352.
160. Osman MO, El-Sefi T, Lausten SB, Jacobsen NO, Larsen CG, Jensen SL: Fusidin and the cytokine response in an experimental model of acute pancreatitis. Br J Surg 1998, in press.
161. Rinderknecht H: Genetic determinants of mortality in acute necrotizing pancreatitis. Int J Pancreatol 1994;16:11-15.
162. Montravers P, Chollet-Martin S, Marmuse JP, Gougerot-Pocidalo MA, Desmonts JM: Lymphatic release of cytokines during acute lung injury complicating severe pancreatitis. Am J Respir Crit Care Med 1995;152:1527-1533.
163. Chollet-Martin S, Montravers P, Gibert C, Elbim C, Desmonts JM, Fagon JY, Gougerot-Pocidalo MA: Sub-population of hyperresponsive polymorphonuclear neutrophils in patients with adult respiratory distress syndrome. Role of cytokine production. Am Rev Respir Dis 1992;146:990-996.
164. Warshaw AL: Damage prevention versus damage control in acute pancreatitis (editorial). Gastroenterology 1993;104:1216-1219.